Revised SPC: Tarivid (ofloxacin) 400 mg Tablets -

Revised SPC: Tarivid (ofloxacin) 400 mg Tablets
Information type: Drug prescribing
Source: electronic Medicines compendium
Specialities: Infection and infectious diseases
Summary
Due to increase in resistance to N. gonorrhoeae, it should not be used as empirical treatment in suspected gonococcal infection, unless the pathogen has been identified and confirmed as susceptible to ofloxacin. Various changes have been made to indications and dosing sections.
UKMi comment
A statement that ofloxacin should only be considered in combination with anaerobe coverage for pelvic inflammatory disease has also been added to section 4.4.
Related links: